STAT August 19, 2024
SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked.
The company — or, at least, what existed at its founding in 2013 — hoped to pull data from images of healthy and diseased cells, and use that data to identify drugs gathering dust on pharmaceutical company shelves that could be repurposed as rare disease treatments.
The founders were a medical school dropout, an entrepreneur whose most recent success was with...